Greenwood Capital Associates LLC Abb Vie Inc. Transaction History

Greenwood Capital Associates LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $97,434 - $123,871	-708 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $1.76 Million - $2.18 Million	-13,342 Reduced 94.96%	708 $115,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $194,233 - $245,761	1,808 Added 14.77%	14,050 $1.9 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $181,731 - $206,292	1,708 Added 16.21%	12,242 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $232,619 - $259,151	2,211 Added 26.56%	10,534 $1.19 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $295,033 - $324,796	2,884 Added 53.02%	8,323 $901,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $144,157 - $194,627	1,791 Added 49.1%	5,439 $582,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $3.23 Million - $3.79 Million	-37,632 Reduced 91.16%	3,648 $320,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $45,660 - $54,897	-725 Reduced 1.73%	41,280 $3 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $2.76 Million - $3.53 Million	42,005 New	42,005 $3.06 Million
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $339,416 - $399,476	-4,400 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $342,540 - $422,444	4,400 New	4,400 $406,000

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.